U.S. Markets open in 7 hrs 8 mins

Top Ranked Value Stocks to Buy for March 22nd

Zacks Equity Research

Here are four stocks with buy rank and strong value characteristics for investors to consider today, March 22nd:

DXC Technology Company (DXC): This information technology services and solutions provider has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 1% over the last 60 days.

DXC Technology Company. Price and Consensus

DXC Technology Company. Price and Consensus

DXC Technology Company. price-consensus-chart | DXC Technology Company. Quote

DXC Technology has a price-to-earnings ratio (P/E) of 7.94, compared with 23.00 for the industry. The company possesses a Value Score of A.

DXC Technology Company. PE Ratio (TTM)

DXC Technology Company. PE Ratio (TTM)

DXC Technology Company. pe-ratio-ttm | DXC Technology Company. Quote

BT Group plc (BT): This communications services provider has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 3% over the last 60 days.

BT Group PLC Price and Consensus

BT Group PLC Price and Consensus

BT Group PLC price-consensus-chart | BT Group PLC Quote

BT has a price-to-earnings ratio (P/E) of 8.86, compared with 14.00 for the industry. The company possesses a Value Score of A.

BT Group PLC PE Ratio (TTM)

BT Group PLC PE Ratio (TTM)

BT Group PLC pe-ratio-ttm | BT Group PLC Quote

Blue Capital Reinsurance Holdings Ltd. (BCRH): This collateralized reinsurance provider in the property catastrophe market has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 7.4% over the last 60 days.

Blue Capital Reinsurance Holdings Ltd. Price and Consensus

Blue Capital Reinsurance Holdings Ltd. Price and Consensus

Blue Capital Reinsurance Holdings Ltd. price-consensus-chart | Blue Capital Reinsurance Holdings Ltd. Quote

Blue Capital Reinsurance has a price-to-earnings ratio (P/E) of 8.99, compared with 23.40 for the industry. The company possesses a Value Score of B.

Blue Capital Reinsurance Holdings Ltd. PE Ratio (TTM)

Blue Capital Reinsurance Holdings Ltd. PE Ratio (TTM)

Blue Capital Reinsurance Holdings Ltd. pe-ratio-ttm | Blue Capital Reinsurance Holdings Ltd. Quote

PPDAI Group Inc. (PPDF): This investment holding company has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 2.1% over the last 60 days.

PPDAI Group Inc. Sponsored ADR Price and Consensus

PPDAI Group Inc. Sponsored ADR Price and Consensus

PPDAI Group Inc. Sponsored ADR price-consensus-chart | PPDAI Group Inc. Sponsored ADR Quote

PPDAI has a price-to-earnings ratio (P/E) of 4.42, compared with 5.20 for the industry. The company possesses a Value Score of A.

PPDAI Group Inc. Sponsored ADR PE Ratio (TTM)

PPDAI Group Inc. Sponsored ADR PE Ratio (TTM)

PPDAI Group Inc. Sponsored ADR pe-ratio-ttm | PPDAI Group Inc. Sponsored ADR Quote

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
PPDAI Group Inc. Sponsored ADR (PPDF) : Free Stock Analysis Report
 
DXC Technology Company. (DXC) : Free Stock Analysis Report
 
BT Group PLC (BT) : Free Stock Analysis Report
 
Blue Capital Reinsurance Holdings Ltd. (BCRH) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research